Overall rank by patents
#32,086
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 12 technology areas, active 2017–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B33Y (ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE ).
The verdict
Incodema3d holds 8 US patents across 12 technology areas, rank #32,086 of 50,000 tracked assignees.
Incodema3d, Llc has been granted 8 US utility patents between 2017 and 2023, placing Incodema3d, Llc at rank #32,086 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.4 claims per patent with primary concentration in B33Y (ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE ). As a US Corporation, Incodema3d, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Incodema3d sits between Imprenditore Pty Ltd. (8 patents, rank #32,082) and Indigo Diabetes N.v. (8 patents, rank #32,090) - the closest US assignees by grant volume. The composite Innovation Score of 34.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 3 in the 2015–2019 window, a +67% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Incodema3d, Llc's 21.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Incodema3d, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Imprenditore Pty Ltd.
8 patents
In2Bones, LLC
8 patents
InSilixa, Inc.
8 patents
InView Technology Corporation
8 patents
Indeed, Inc.
8 patents
Index Pharmaceuticals AB
8 patents
Indiggo LLC
8 patents
Indigo Diabetes N.V.
8 patents
Incodema3D, LLC
8 patents
What this shows Incodema3d holds 8 patents at rank #32,086, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,086 in granted patent volume.
Other assignees with the most granted patents in Incodema3d's primary technology class.
Incodema3d's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
34 Top 54% higher than 46% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
| 2019 | 1 | 12.5% |
| 2020 | 2 | 25.0% |
| 2021 | 2 | 25.0% |
| 2023 | 1 | 12.5% |
Top 12 of 12 technology areas
Overall rank by patents
#32,086
Across all tracked assignees
34.0 out of 100
How to use this portfolio
Incodema3d's 8 grants land it in the top 54% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.